Intelligent Surgical Lasers, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Plans secondary offering of 3 mil. units at an anticipated price of $5 per unit. Each unit would consist of one share of common stock and one Class A and one Class B redeemable common stock purchase warrant. "The number of units to be offered reflects the implementation of a currently contemplated .4 for 1 reverse [stock] split," the firm announced Oct. 1. D. Blech & Co. will underwrite the offering. "Less than 10% of the proceeds" are anticipated to be used to retire $1.7 mil. in bridge financing provided by "certain" shareholders and an investment banking firm. The firm reported a loss of $5.4 mil. for fiscal 1993 (ended June 30) on sales of $1.9 mil.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.